Company Overview
Sales
435
Cr
Growth: 0.0%
Profit after Tax
33.9
Cr
Growth:
9.2%
Small Cap
828
Cr
P/E:
24.7x
Industry P/E: 33.7x
Fundamentals
| Sales (Cr) |
₹ 435 |
| Growth |
0.0% |
| EBITDA |
12.2% |
| P/S |
1.9x |
| Dividend |
0.0% |
| P/E |
24.7x |
| Book Value |
₹ 19 |
| PEG Ratio |
N/A |
| ROE |
16.6% |
| P/B |
3.6x |
Shareholding Pattern
Increase
Decrease
No change
The company is engaged in manufacturing and trading of nutraceuticals clinical or dietary supplements, micronutrient premixes and animal feed. Micronutrient Premix business of the company focuses on the needs of fortifying basic foods with the right blend of micronutrients to meet the needs of the masses. Clinical Nutrition or Dietary Supplements offered by the company is intended to provide nutrients that may otherwise not be consumed in sufficient quantities by the masses.
